72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Inflammatory bowel diseases: time of diagnosis, environmental factors, clinical course, and management – a follow-up study in a private inflammatory bowel disease center (2003–2017)

, &
Pages 127-135 | Published online: 28 May 2019

References

  • Vinter-RepalustNChronic inflammatory bowel diseases – specific aspects of family physician careActa Med Croatica201569439539929084418
  • CarlssonEPerssonELiving with intestinal failure caused by Crohn disease: not letting the disease conquer lifeGastroenterol Nurs2015381122025636009
  • KempKGriffithsJLovellKUnderstanding the health and social care needs of people living with IBD: a meta-synthesis of the evidenceWorld J Gastroenterol20121843624023180944
  • LoftusEVCrohn’s disease: etiology, complications, assessment, therapy, and managementGastroenterology Clinics of North America2017463xiii0
  • ZhouMHeJShenYZhangCWangJChenYNew frontiers in genetics, gut microbiota, and immunity: a Rosetta stone for the pathogenesis of inflammatory bowel diseaseBioMed Research International201720179117
  • MaaserCLangholzEGordonHDOP001 European Crohn’s and colitis organisation topical review on environmental factors in IBDJ Crohns Colitis201711suppl_1S26920
  • CuryDBMizsputenSJVersolatoCSerum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisCell Immunol20132821667023685388
  • OrtizoRLeeSYNguyenETJamalMMBechtoldMMNguyenDLExposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studiesEur J Gastroenterol Hepatol20172991064107028542115
  • CuryDHBCostaJEIrikaKProtective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel diseaseDig Dis Sci20085392516252018351467
  • BurkeKEBoumitriCAnanthakrishnanANModifiable environmental factors in inflammatory bowel diseaseCurr Gastroenterol Rep20171952128397132
  • BiancoAMGirardelliMTommasiniAGenetics of inflammatory bowel disease from multifactorial to monogenic formsWorld J Gastroenterol20152143122961231026604638
  • FlanaganPCampbellBJRhodesJMBacteria in the pathogenesis of inflammatory bowel diseaseBiochem Soc Trans20113941067107221787349
  • LiSXThompsonKDPetersonTDelivering high value inflammatory bowel disease care through telemedicine visitsInflamm Bowel Dis201723101678168128817463
  • BurischJVardiHPedersenNCosts and resource utilization for diagnosis and treatment during the initial year in a European Inflammatory bowel disease inception cohort: an ECCO-EpiCom studyInflamm Bowel Dis201521112113125437816
  • Peyrin-BirouletLWhat is the patient’s perspective: how important are patient-reported outcomes, quality of life and disability?Dig Dis201028346347120926873
  • deSBFRCarvalhoATPdeVCAThe socio-economic impact of work disability due to inflammatory bowel disease in BrazilEur J Health Economics2017
  • BernsteinCNEliakimAFedailSWorld gastroenterology organisation global guidelines inflammatory bowel disease: update August 2015J Clin Gastroenterol2016501080381827741097
  • LopezRNEvansHMAppletonLPoint prevalence of pediatric inflammatory bowel disease in New Zealand in 2015: initial results from the PINZ studyInflamm Bowel Dis20172381418142428570430
  • DäbritzJGernerPEnningerAClaßenMRadkeMInflammatory bowel disease in childhood and adolescenceDtsch Arztebl Int20171141933133828597827
  • KaplanGGNgSCGlobalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and ChinaLancet Gastroenterol Hepatol20161430731628404201
  • LophavenSNLyngeEBurischJThe incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort studyAliment Pharmacol Ther201745796197228229470
  • BurischJMunkholmPThe epidemiology of inflammatory bowel diseaseScand J Gastroenterol201550894295125687629
  • GuarisoGGasparettoMTreating children with inflammatory bowel disease: current and new perspectivesWorld J Gastroenterol201723305469548528852307
  • AkereAOkeTOOtegbayoJAColonoscopy at a tertiary healthcare facility in Southwest Nigeria: spectrum of indications and colonic abnormalitiesAnn Afr Med201615310911327549414
  • denYKinoshitaJDeshpandeGAHiraokaEAmoebiasis masquerading as inflammatory bowel diseaseBMJ Case Rep20152015
  • SantosRMDCarvalhoATPSilvaKDSSáSPCSantosAHDSandinhaMRInflammatory bowel disease: Outpatient treatment profileArq Gastroenterol20175429610028198912
  • da SilvaBCLyraACMendesCMCThe demographic and clinical characteristics of ulcerative colitis in a northeast Brazilian populationBioMed Research International20152015118
  • ParenteJMLCoyCSRCampeloVInflammatory bowel disease in an underdeveloped region of northeastern BrazilWorld J Gastroenterol20152141197120625632193
  • FarrukhAMayberryJFInflammatory bowel disease in Hispanic Communities: a concerted South American approach could identify the aetiology of Crohn’s disease and ulcerative colitisArq Gastroenterol201451427127525591153
  • da SilvaBCLyraACRochaRSantanaGOEpidemiology, demographic characteristics and prognostic predictors of ulcerative colitisWorld J Gastroenterol201420289458946725071340
  • OliveiraFMEmerickAPCSoaresEGEpidemiology aspects of inflammatory bowel disease in the east region of Minas Gerais StateCien Saude Colet201015Suppl 11031103720640259
  • Brazilian Study Group of Inflammatory Bowel DiseasesConsensus guidelines for the management of inflammatory bowel diseaseArquivos de Gastroenterologia201047331332521140096
  • BianconeLAnneseVArdizzoneSSafety of treatments for inflammatory bowel disease: clinical practice guidelines of the Italian Group for the study of inflammatory bowel disease (IG-IBD)Dig Liver Dis201749433835828161290
  • SpekhorstLMVisschedijkMCAlbertsRPerformance of the Montreal classification for inflammatory bowel diseasesWorld J Gastroenterol20142041153741538125386087
  • LoftusEVClinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influencesGastroenterology200412661504151715168363
  • FernandesABacalhauSCabralJPediatric inflammatory bowel disease: is it still increasing?Acta Medica Portuguesa201124Suppl 2 Portuguese
  • BhanNMillettCSubramanianSVSocioeconomic patterning of chronic conditions and behavioral risk factors in rural South Asia: a multi-site cross-sectional studyInt J Public Health20176291019102828756464
  • AbegundeATMuhammadBHBhattiOAliTEnvironmental risk factors for inflammatory bowel diseases: evidence based literature reviewWorld J Gastroenterol201622276296631727468219
  • NgSCEpidemiology of inflammatory bowel disease: focus on AsiaBest Pract Res Clin Gastroenterol201428336337224913377
  • ZakhariaKTabibianALindorKDTabibianJHComplications, symptoms, quality of life and pregnancy in cholestatic liver diseaseLiver Int201838339941128921801
  • ByeWANguyenTMParkerCEJairathVEastJECochrane IBD GroupStrategies for detecting colon cancer in patients with inflammatory bowel diseaseCochrane Database of Systematic Reviews2017132CD000279
  • Chrobak-BieńJGaworAPaplaczykMMałecka-PanasEGąsiorowskaAAnalysis of factors affecting the quality of life of those suffering from Crohn’s diseasePol Przegl Chir20178941622
  • CantoroLdi SabatinoAPapiCThe time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an Italian multicentre studyJ Crohns Colitis201711897598028333328
  • KediaSAhujaVEpidemiology of inflammatory bowel disease in India: the great shift EastInflamm Intest Dis20172210211530018961
  • NgWKWongSHNgSCChanging epidemiological trends of inflammatory bowel disease in AsiaIntest Res [Internet]20164 January 10, 20191421119
  • YangS-KHow does the epidemiology of inflammatory bowel disease differ between East and West? a Korean perspectiveInflamm Intest Dis2017229510130018960
  • DelmondesLMNunesMOAzevedoARMmdesOliveiraCoelhoLERTorres-NetoJdarClinical and sociodemographic aspects of inflammatory bowel disease patientsGastroenterology Res201583–420721527785298
  • VictoriaCRSassakLYNunesHrdecIncidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, BrazilArq Gastroenterol2009461202519466305
  • GaburriPDChebliJMde CastroLEEpidemiology, clinical features and clinical course of Crohn’s disease: a study of 60 casesArq Gastroenterol1998354240246 Portuguese10347705
  • BergAMDamANFarrayeFAEnvironmental influences on the onset and clinical course of Crohn’s disease-part 2: infections and medication useGastroenterol Hepatol2013912803810
  • van der SlootKWJAminiMPetersVDijkstraGAlizadehBZInflammatory bowel diseases: review of known environmental protective and risk factors involvedInflamm Bowel Dis20172391499150928777099
  • SunWHanXWuSYangCTonsillectomy and the risk of inflammatory bowel disease: a systematic review and meta-analysisJ Gastroenterol Hepatol20163161085109426678358
  • SolbergICLygrenIJahnsenJClinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN study)Scand J Gastroenterol200944443144019101844
  • NguyenVQJiangDHoffmanSNImpact of diagnostic delay and associated factors on clinical outcomes in a U.S. Inflammatory bowel disease cohortInflamm Bowel Dis201723101825183128885229
  • CuryDBMossACSchorNNephrolithiasis in patients with inflammatory bowel disease in the communityInt J Nephrol Renovasc Dis2013613923935383
  • CuryDBMossACOcular manifestations in a community-based cohort of patients with inflammatory bowel diseaseInflamm Bowel Dis20101681393139619998457